Skip to Main Content

Paper Details

Medical and Non-medical Costs of Sickle Cell Disease and Treatments from a US Perspective: A Systematic Review and Landscape Analysis.
Pharmacoecon Open
11
2022
Author NameAffiliation
Emily Beth Devineand Economics (CHOICE) Institute, University of Washington
Emily Beth DevineDepartment of Health Services, University of Washington
  • 1 - 2

Datasets

Release 1.2